2023 Form 5500 filing — C3j Therapeutics, Inc.

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240923154614NAL0020790944001) for C3j Therapeutics, Inc., reported by C3j Therapeutics, Inc. under EIN 81-2701888 and plan number 001. It reports 84 participants. Attached schedules in the loaded dataset include Schedule I (small plan financials).

Form 5500 2 · 2023

Filing snapshot

Net assets (EOY)$3.3MReported net assets$3,258,572
Participants84
Provider compensationNone reported
Schedules filedSchedule ILoaded schedules
EFAST2 acknowledgement
20240923154614NAL0020790944001
Plan sponsor
C3j Therapeutics, Inc.
EIN
81-2701888
Plan number
001
Location
Los Angeles, CA
Received date
not reported in the loaded dataset
How to read this filing
  • This is a single annual Form 5500 filing, identified by its EFAST2 acknowledgement id.
  • Schedule chips (Sch H / I / C) show which schedules this filing includes.
  • Net assets = total assets minus total liabilities (Schedule H/I).
  • Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
  • For the plan's full history, open the plan profile.
Schedule I · 2023

Reported financial snapshot

Reported figures as filed, in whole dollars. Only fields the filing reports are shown.

Reported balance (end of year)$3.3M total assets
Net assets$3.3MLiabilities$0
Money in vs. money out
Total income / additions$1.1M
Total expenses$490.5K
Benefits paid / distributions$478.4K
Contributions
Employer$173.7K
Participant$558.2K
Full reported line items
Total assets (EOY)
$3,258,572
Total liabilities (EOY)
$0
Net assets (EOY)
$3,258,572
Employer contributions
$173,736
Participant contributions
$558,214
Total income / additions
$1,140,386
Benefits paid
$478,446
Administrative expenses
$6,419
Total expenses
$490,519
Net increase / (decrease)
$649,867

What to inspect next

Frequently asked questions

What does EFAST2 acknowledgement 20240923154614NAL0020790944001 cover?
It is the 2023 Form 5500 filing for C3j Therapeutics, Inc., reported by C3j Therapeutics, Inc. (EIN 81-2701888).
Which Form 5500 schedules are attached to this 2023 filing?
Attached schedules in the loaded dataset include Schedule I (small plan financials).

Related Form 5500 pages